First clinical trial involving human embryonic stem cells gets underway in Chicago
September 24, 2010
Enrollment has begun for the first clinical trial to test a therapy developed from human embryonic stem cells.
The trial’s primary aim is to assess the safety of Geron Corp.’s experimental oligodendrocyte progenitor cells, which have been in development for about a decade. They were derived from some of the earliest human embryonic stem cells ever created. (Los Angeles Times)
